ADVENZYMES
Advanced Enzyme Tech
Each stock's 10,000-path forecast, rendered as light.
Advanced Enzyme Tech (ADVENZYMES) Stock Analysis & Case Study
Is ADVENZYMES a good buy? The data-driven verdict.
on the numbers it tread carefully, a Downstox Snapshot Score of 44/100.
On the numbers, Advanced Enzyme Tech (ADVENZYMES) tread carefully, a Downstox Snapshot Score of 44/100, weighing a 42% model probability of trading higher in a year. Below: the full bull case, bear case, sector-relative valuation, and a probability-weighted price target for 2027–2031.
Last updated . Data snapshot for research, not investment advice.
ADVENZYMES share price target 2027, 2028, 2029, 2030, 2031, a probability view
Unlike a single guessed number, this is a probability-weighted range from a 10,000-path Monte-Carlo simulation on 2.0y of ADVENZYMES history (-1%/yr drift, 40%/yr volatility).
| Year | Low (P10) | Median target (P50) | High (P90) | Upside vs today |
|---|---|---|---|---|
| ADVENZYMES 2027 | ₹205 | ₹346 | ₹581 | -7% |
| ADVENZYMES 2028 | ₹150 | ₹314 | ₹643 | -16% |
| ADVENZYMES 2029 | ₹116 | ₹286 | ₹684 | -23% |
| ADVENZYMES 2030 | ₹91 | ₹257 | ₹721 | -31% |
| ADVENZYMES 2031 | ₹75 | ₹235 | ₹747 | -37% |
Median (P50) is the central estimate; the P10–P90 band is the 80% confidence range. Probabilities, not promises.
What is the probability ADVENZYMES goes up, or doubles?
The bull case for ADVENZYMES
- Advanced Enzyme Tech is part of the NSE universe with live, tracked fundamentals on Downstox.
- Upside scenario: the model's optimistic (P90) 3-year path reaches ₹684.
The bear case & risks
- The probability model is cautious 12 months out, only a 42% chance of finishing above today's price.
- Downside scenario: the model's pessimistic (P10) 3-year path falls to ₹116.
ADVENZYMES volatility & expected range, how bumpy is the ride?
Over the last 2.0 years ADVENZYMES compounded at -1%/year with annualized volatility of 40%. That volatility implies a 1-year 80% range of ₹205–₹581, the honest backbone behind any single price target.
ADVENZYMES price forecast, the full 60-month probability fan
ADVENZYMES price probability fan
Each band shows where 10,000 simulated paths land. The wider the fan, the more uncertainty.
Probability of key outcomes
What are the odds ADVENZYMES hits common targets within the simulated horizon?
Full multi-horizon detail on the ADVENZYMES price target & forecast page.
ADVENZYMES MTF margin & leverage, Upstox, Zerodha, Groww, Dhan
Margin Trading Facility lets you buy ADVENZYMES with part of the capital. Lower margin % = higher leverage. Rates compared across brokers (no competitor publishes this):
| Broker | Margin required | Approx. leverage |
|---|---|---|
| Upstox | 35.0% | 2.9× |
| ZerodhaCHEAPEST | 33.4% | 3.0× |
| DhanCHEAPEST | 33.4% | 3.0× |
Compare every broker on the ADVENZYMES MTF page.
ADVENZYMES vs peers,sector comparison
About Advanced Enzyme Tech: sector, index & market-cap context
Advanced Enzyme Tech (ADVENZYMES) is an NSE-listed company.
How the ADVENZYMES Snapshot Score & forecast are built
The Downstox Snapshot Score is a transparent, rules-based read of Advanced Enzyme Tech's public fundamentals plus a statistical forecast, not an analyst opinion. It rewards low-to-fair valuation, high ROE/ROCE, a strong Piotroski F-Score, a dividend, low volatility and a favourable probability of upside; it penalises rich valuations, weak capital efficiency, a low F-Score and high volatility. The price target is a 10,000-path Monte-Carlo simulation on real historical volatility, a distribution, not a single guess. The bull and bear cases are generated from the same data, so you always see both sides.
This is information, not investment advice. Do your own due diligence and consult a SEBI-registered adviser before investing.
ADVENZYMES analysis, FAQs
Is Advanced Enzyme Tech (ADVENZYMES) a good buy?
On the numbers, Advanced Enzyme Tech (ADVENZYMES) tread carefully, a Downstox Snapshot Score of 44/100, weighing a 42% model probability of trading higher in a year. This is a data snapshot for research, not investment advice.
Is ADVENZYMES overvalued or undervalued?
Valuation ratios for ADVENZYMES are tracked live on Downstox.
What is the ADVENZYMES share price target for 2031?
ADVENZYMES's probability-weighted 2031 median target is ₹235, with an 80% range of ₹75–₹747 (10,000-path Monte-Carlo).
What is the probability ADVENZYMES doubles in 5 years?
The modelled probability of ADVENZYMES reaching ₹747 (2×) within 5 years is 10%.
What is the bull case for ADVENZYMES?
Advanced Enzyme Tech is part of the NSE universe with live, tracked fundamentals on Downstox.
What are the risks in ADVENZYMES?
The probability model is cautious 12 months out, only a 42% chance of finishing above today's price.